These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 24661570)
1. Role of alpha-1 antitrypsin in human health and disease. de Serres F; Blanco I J Intern Med; 2014 Oct; 276(4):311-35. PubMed ID: 24661570 [TBL] [Abstract][Full Text] [Related]
2. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update. Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067 [TBL] [Abstract][Full Text] [Related]
3. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy. Campos MA; Lascano J Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223 [TBL] [Abstract][Full Text] [Related]
4. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774 [TBL] [Abstract][Full Text] [Related]
5. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency. Tirado-Conde G; Lara B; Miravitlles M Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355 [TBL] [Abstract][Full Text] [Related]
6. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study. Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328 [TBL] [Abstract][Full Text] [Related]
7. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies. Tonelli AR; Brantly ML Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978 [TBL] [Abstract][Full Text] [Related]
8. Alpha-1-antitrypsin deficiency. Bals R Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965 [TBL] [Abstract][Full Text] [Related]
9. A review of alpha-1 antitrypsin deficiency. Ranes J; Stoller JK Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434 [TBL] [Abstract][Full Text] [Related]
11. Alpha1-antitrypsin deficiency: incidence and implications. Richmond RJ; Zellner KM Dimens Crit Care Nurs; 2005; 24(6):255-60; quiz 261-2. PubMed ID: 16327507 [TBL] [Abstract][Full Text] [Related]
12. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis. Barjaktarevic I; Miravitlles M BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Blanco I; Lara B; de Serres F Orphanet J Rare Dis; 2011 Apr; 6():14. PubMed ID: 21486454 [TBL] [Abstract][Full Text] [Related]
15. The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting. Molina J; Flor X; García R; Timiraos R; Tirado-Conde G; Miravitlles M Ther Adv Respir Dis; 2011 Aug; 5(4):237-43. PubMed ID: 21652608 [TBL] [Abstract][Full Text] [Related]
16. Serum levels and genotype distribution of α1-antitrypsin in the general population. Ferrarotti I; Thun GA; Zorzetto M; Ottaviani S; Imboden M; Schindler C; von Eckardstein A; Rohrer L; Rochat T; Russi EW; Probst-Hensch NM; Luisetti M Thorax; 2012 Aug; 67(8):669-74. PubMed ID: 22426792 [TBL] [Abstract][Full Text] [Related]
17. The discovery of α1-antitrypsin and its role in health and disease. Janciauskiene SM; Bals R; Koczulla R; Vogelmeier C; Köhnlein T; Welte T Respir Med; 2011 Aug; 105(8):1129-39. PubMed ID: 21367592 [TBL] [Abstract][Full Text] [Related]
18. Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse? Schmechel DE Neurotoxicology; 2007 Sep; 28(5):899-914. PubMed ID: 17659342 [TBL] [Abstract][Full Text] [Related]